Viking Global Investors Portfolio holdings
AUM
$37.7B
1-Year Est. Return
26.76%
This Fund
S&P 500
1 Year Est. Return
+26.76%
AUM
$37.7B
AUM Growth
-$827M
(-2.1%)
Holding
99
Top Buys
| 1 | +$762M | |
| 2 | +$752M | |
| 3 | +$715M | |
| 4 |
Dick's Sporting Goods
DKS
|
+$561M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$449M |
Top Sells
| 1 | +$988M | |
| 2 | +$976M | |
| 3 | +$722M | |
| 4 |
Philip Morris
PM
|
+$718M |
| 5 |
Meta Platforms (Facebook)
META
|
+$682M |
Sector Composition
| 1 | Financials | 23.65% |
| 2 | Consumer Discretionary | 19.94% |
| 3 | Technology | 15.37% |
| 4 | Healthcare | 13.34% |
| 5 | Industrials | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arthur J. Gallagher & Co
AJG
$57.7B
| $269M | 0.72% |
+1,040,977
|
|
||
52
Bank of America
BAC
$381B
| $247M | 0.66% |
4,494,629
-7,005,661
|
|
||
53
Boston Scientific
BSX
$88.5B
| $239M | 0.64% |
2,509,808
-131,874
|
|
||
54
Digital Realty Trust
DLR
$69.2B
| $233M | 0.62% |
+1,507,988
|
|
||
55
Lowe's Companies
LOW
$141B
| $220M | 0.58% |
+912,040
|
|
||
|
FIG
56
Figma
FIG
$9.77B
| $215M | 0.57% |
+5,752,388
|
|
||
57
Itaú Unibanco
ITUB
$100B
| $203M | 0.54% |
+28,396,545
|
|
||
58
Amer Sports
AS
$21B
| $180M | 0.48% |
4,814,290
-1,529,191
|
|
||
|
RAL
59
Ralliant Corp
RAL
$5.18B
| $161M | 0.43% |
3,162,630
-1,919,842
|
|
||
60
Riot Platforms
RIOT
$6.6B
| $157M | 0.42% |
+12,428,894
|
|
||
61
NewAmsterdam Pharma
NAMS
$3.73B
| $147M | 0.39% |
4,203,567
-2,271,967
|
|
||
62
Roivant Sciences
ROIV
$21B
| $140M | 0.37% |
6,443,191
-17,151,640
|
|
||
63
IQVIA
IQV
$29.5B
| $140M | 0.37% |
+619,236
|
|
||
|
SION
64
Sionna Therapeutics
SION
$1.88B
| $131M | 0.35% |
3,195,181
|
|
||
65
Inhibrx
INBX
$1.23B
| $114M | 0.3% |
1,437,705
-350,000
|
|
||
66
Pharvaris
PHVS
$1.91B
| $101M | 0.27% |
3,653,310
|
|
||
67
CoStar Group
CSGP
$16.3B
| $97M | 0.26% |
1,442,582
-407,147
|
|
||
68
West Pharmaceutical
WST
$19.8B
| $81.2M | 0.22% |
+295,028
|
|
||
|
ORKA
69
Oruka Therapeutics
ORKA
$3.42B
| $80.8M | 0.21% |
2,666,690
|
|
||
70
Standard BioTools
LAB
$374M
| $75.1M | 0.2% |
58,651,170
|
|
||
71
Masimo
MASI
$9.34B
| $66.9M | 0.18% |
514,340
-559,093
|
|
||
72
Oric Pharmaceuticals
ORIC
$1.19B
| $53.8M | 0.14% |
6,572,691
-9
|
|
||
73
Trevi Therapeutics
TRVI
$1.88B
| $40M | 0.11% |
3,198,644
-1,930,231
|
|
||
74
Ginkgo Bioworks
DNA
$508M
| $29.7M | 0.08% |
3,577,128
|
|
||
75
PepGen
PEPG
$111M
| $22.7M | 0.06% |
3,482,434
|
|